Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Raven McCloud who wrote (429)	3/16/1999 12:22:00 PM
From: 5,17,37,5,101,...	Read Replies (2) \| Respond to of 2515

What you're witnessing is typical IMCL price action, movement on very little volume. The move from $8.00 to $11.00 occurred on a smidgeon of recent millions traded but in percentage terms is more than the move from $11.00 to $14.00. So lots of volume really hasn't gotten us very far (and lots of publicity), barely really above 1998 high. This is worrisome. Either we say as traders that there's a lot of skepticism out there which can mean much higher prices later, or we say savvy investors are unloading. I believe the stock is worth $20.00 - $24.00 (see previous posts); however, that doesn't preclude a move back to $12.00, or in a ditching market maybe $9.00 again. I also am tempted to sell my trading shares here again due to the feeling that news related to C225 in PIII will be sparse for a while leaving us open to price decline. On the other hand, news related to stem cells or one of the other C225 trials or BEC2 etc that would push the stock up a few points should be imminent. Jackson